• Exchange: NASDAQ GM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Insys Therapeutics Inc

+ Add to Watchlist

INSY:US

34.8800 USD 0.3401 0.98%

As of 20:10:00 ET on 08/28/2014.

Snapshot for Insys Therapeutics Inc (INSY)

Open: 34.5300 Day's Range: 34.5001 - 35.5000 Volume: 318,547
Previous Close: 34.5399 52wk Range: 18.3933 - 57.9133 1-Yr Rtn: +77.96%

Stock Chart for INSY

No chart data available.
  • INSY:US 34.9100
  • 1D
  • 1M
  • 1Y
34.5399
Interactive INSY Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for INSY

Current P/E Ratio (ttm) 17.5276
Estimated P/E(12/2014) 21.1394
Relative P/E vs. SPX 0.9780
Earnings Per Share (USD) (ttm) 1.9900
Est. EPS (USD) (12/2014) 1.6500
Est. PEG Ratio 0.8995
Market Cap (M USD) 1,203.72
Shares Outstanding (M) 34.51
30 Day Average Volume 597,547
Price/Book (mrq) 9.9022
Price/Sale (ttm) 5.7340
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 11/12/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for INSY

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for INSY

Insys Therapeutics, Inc. develops cancer support drugs. The Company's support care candidates include a fast-acting sublingual spray for cancer pain, and a dronabinol product used to treat chemotherapy-induced nausea and vomiting and to stimulate appetite in AIDS patients.

John N KapoorChairmanMichael L BabichPresident/CEO
Darryl S BakerChief Financial OfficerChristopher F HomrichSenior VP:Operations
More Company Profile & Key Executives for INSY

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil